Dexcom CGM (DXCM): Enterprise Value to EBITDA Ratio
DexCom, Inc. (DXCM) maintains stable management that is successfully transforming commercial approaches and expanding its audience reach. Technological synergy is achieved through partnerships with wearable gadget developers and insulin pump manufacturers. The brand's flawless image is built upon the creation of ultra-precise glucose monitoring systems. The company's EV/EBITDA ratio over the time series demonstrates business valuation dynamics, where the value 19.97 characterizes this level.
Comprehensive metric breakdowns and analytics for dexcom.com (DXCM)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
DXCM - Net Financial Result|Projected Future Earnings DexCom, Inc.|DXCM - Price to Earnings Ratio|Forward P/E Multiple DexCom, Inc.|DXCM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dexcom CGM|DXCM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Dexcom|DXCM - Earnings per share for the trailing year|Quarterly EPS earnings growth dexcom.com|DXCM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year DexCom, Inc.
Analysis of all company metrics:Dexcom Corp DXCM
This metric combines market value and net debt, comparing them against operating profit before depreciation and amortization. This indicator allows for an assessment of real debt risk and business value relative to its ability to generate cash flow. For DexCom, Inc. (DXCM), this is critical, as innovation costs and insurance programs impact leverage. By analyzing the EV/EBITDA ratio while accounting for financial leverage, an investor can determine the company's resilience to its debt load.
Competitor analysis
Penumbra Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Novanta Photonics NOVT|HAE: Enterprise Value to EBITDA Ratio|inspiresleep.com - Enterprise Value to Operating Income Before Depreciation Ratio|PRCT: EV/EBITDA Multiple|CNMD - Total Company Value to Operating Income Before Depreciation Ratio|PLSE (Pulse Corp) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InMode MD (INMD)|Enterprise Value to EBITDA Ratio PMI (Picard Medical Inc)|SRDX (surmodics.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings Inc SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CUTR|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|reshapelifesciences.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
